Next Article in Journal
Comparative Analysis of Cotton Small RNAs and Their Target Genes in Response to Salt Stress
Next Article in Special Issue
Deciphering the Relationship between Obesity and Various Diseases from a Network Perspective
Previous Article in Journal
Molecular Investigation of the Stem Snap Point in Textile Hemp
Previous Article in Special Issue
Genes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function

Noel T. Mueller
Hakdong Shin
Aline Pizoni
Isabel C. Werlang
Ursula Matte
Marcelo Z. Goldani
Helena A. S. Goldani
4,5 and
Maria G. Dominguez-Bello
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, MD 21205, USA
Department of Food Science and Biotechnology, College of Life Science, Sejong University, Seoul 05006, Korea
Post Graduate Program Sciences in Gastroenterology and Hepatology, Federal University of Rio Grande do Sul, Porto Alegre, RS 90040-060, Brazil
Post Graduate Program in Child and Adolescent Health, Federal University of Rio Grande do Sul, Porto Alegre, RS 90040-060, Brazil
Division of Translational Medicine, New York University School of Medicine, New York, NY 10016, USA
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Genes 2017, 8(12), 364;
Submission received: 18 October 2017 / Revised: 21 November 2017 / Accepted: 23 November 2017 / Published: 4 December 2017
(This article belongs to the Special Issue Diabetes, Obesity and the Gut Microbiome)


Cesarean (C-section) delivery, recently shown to cause excess weight gain in mice, perturbs human neonatal gut microbiota development due to the lack of natural mother-to-newborn transfer of microbes. Neonates excrete first the in-utero intestinal content (referred to as meconium) hours after birth, followed by intestinal contents reflective of extra-uterine exposure (referred to as transition stool) 2 to 3 days after birth. It is not clear when the effect of C-section on the neonatal gut microbiota emerges. We examined bacterial DNA in carefully-collected meconium, and the subsequent transitional stool, from 59 neonates [13 born by scheduled C-section and 46 born by vaginal delivery] in a private hospital in Brazil. Bacterial DNA was extracted, and the V4 region of the 16S rRNA gene was sequenced using the Illumina MiSeq (San Diego, CA, USA) platform. We found evidence of bacterial DNA in the majority of meconium samples in our study. The bacterial DNA structure (i.e., beta diversity) of meconium differed significantly from that of the transitional stool microbiota. There was a significant reduction in bacterial alpha diversity (e.g., number of observed bacterial species) and change in bacterial composition (e.g., reduced Proteobacteria) in the transition from meconium to stool. However, changes in predicted microbiota metabolic function from meconium to transitional stool were only observed in vaginally-delivered neonates. Within sample comparisons showed that delivery mode was significantly associated with bacterial structure, composition and predicted microbiota metabolic function in transitional-stool samples, but not in meconium samples. Specifically, compared to vaginally delivered neonates, the transitional stool of C-section delivered neonates had lower proportions of the genera Bacteroides, Parabacteroides and Clostridium. These differences led to C-section neonates having lower predicted abundance of microbial genes related to metabolism of amino and nucleotide sugars, and higher abundance of genes related to fatty-acid metabolism, amino-acid degradation and xenobiotics biodegradation. In summary, microbiota diversity was reduced in the transition from meconium to stool, and the association of delivery mode with microbiota structure, composition and predicted metabolic function was not observed until the passing of the transitional stool after meconium.

1. Introduction

C-section delivery is a common surgical procedure intended to increase the chances of successful delivery and to protect the health of the mother. Yet this highly overused intervention [1,2,3,4] has been associated with higher offspring risk of immune and metabolic disorders [5,6,7,8] and shown to cause excess weight gain in a murine model [9]. It is hypothesized that these associations are due to C-section-delivered neonates not receiving the full inoculum of maternal microbes at birth [7].
Neonates delivered vaginally are exposed to maternal vaginal microbiota in labor, and additionally to maternal intestinal microbiota at birth [10,11,12,13]. C-section and the prophylactic antibiotics administered during this surgery [14] may cause newborns to miss this natural microbial inoculum [14,15,16]. C-section-delivered neonates are first exposed to microbes from the delivery room [17] and maternal skin (e.g., Staphylococcus and Corynebacterium) [15]. Recent longitudinal studies suggest the postnatal impact of delivery mode on the infant microbiome may extend for up to two years [16,18]. Yet, since the intestine of the newborn at birth is filled with in-utero contents, which are passed postnatally as meconium, it is unclear when the differences in the gut microbiota of C-section versus vaginally-delivered neonates begin to emerge.
Findings of bacterial DNA in the placenta, amniotic fluid, and newborn meconium have given rise to the hypothesis that the human fetus may be exposed to microbiota in utero through ingestion of amniotic fluid [16,19,20,21]. Yet no evidence exists for fetal exposure to live bacteria in healthy pregnancies. If microbiota colonize the fetal intestinal tract before labor and birth, this microbial colony should be reflected in the meconium, but not be impacted, or be impacted to a lesser extent, by delivery mode. Thus, we hypothesized that a higher delivery-mode signal should be found in the microbiota of the feces passed after meconium (i.e., transitional stool). To test this hypothesis, we compared the composition, structure and predicted metabolic function of microbiota in meconium and the subsequent transitional stool from neonates born by scheduled elective C-section vs. vaginal delivery.

2. Materials and Methods

2.1. Design and Subjects

Trained staff invited women to participate in the study if they were scheduled for a vaginal delivery or an elective C-section delivery between 38 and 42 weeks of gestation (confirmed by an ultrasound taken before the 20th week of pregnancy) in the participating private hospital in Porto Alegre, Brazil. Women were not eligible for the study if they were administered oral antibiotics in the third trimester of pregnancy; if they had diabetes, hypertensive disorders, autoimmune disorders, or HIV/AIDS during pregnancy; if they had smoked during pregnancy; or if they were on a restrictive diet during pregnancy. For vaginal births, we further only included women whose water broke less than 12 h before delivery. All vaginal deliveries were by spontaneous vaginal birth and no instruments were used. Women also had to consent to allowing study staff collect meconium or stool from their neonate, and to completing a postnatal questionnaire. The Research and Ethics Committee of the Hospital de Clinicas (protocol No. 11/0388) and the Hospital Mae de Deus (protocol No. 524/11) in Porto Alegre, Brazil, approved the study protocols and consent.
From medical records, we ascertained information on mode of delivery, gravidity, parity, history of urinary tract infection during pregnancy, antibiotic use during pregnancy, birth weight, labor length, head circumference, placenta weight, sex and race. Other clinical information was derived from a questionnaire administered after birth before discharge.

2.2. Sample Collection and 16S Ribosomal RNA Sequencing

Of the 89 mother-child pairs who consented and enrolled in the original study, we were able to collect 78 meconium samples (collected within 48 h of birth; all but 2 were collected <24 h). From the 78 meconium samples, 59 (75.6%) had detectable bacterial DNA. Transitional stool samples (collected 2–3 days after birth) with detectable bacterial DNA for analysis were available for 50 of 59 of these neonates. All specimens were collected from diapers with sterile spatulas, transferred to sterile tubes, which were kept at 4 °C for <6 h, and then frozen at −80 °C until DNA extraction.
Total DNA was extracted using QIAamp® DNA Stool mini kit (QIAGEN) according to the manufacturer’s instructions. After DNA extraction (200 µL of final volume), we concentrated DNA samples to 20 µL using 3 M Na Acetate precipitation and kept it stored at −20 °C. We determined the DNA concentration of prepared samples using the Quant-iT PicoGreen dsDNA reagent and kit (Invitrogen, Grand Island, NY, USA) based on the manufacturer’s instructions. We amplified the V4 region of the 16S ribosomal RNA (rRNA) gene by polymerase chain reaction (PCR) using the Illumina-adapted universal primers 515F/806R [22]. PCR was done in triplicate using the Bio-Rad CFX 96 thermal cycler (Bio-Rad, Hercules, CA, USA). We then pooled the amplicons in equimolar ratios, purified them using QIA quick PCR purification kit (Qiagen Inc., Chatsworth, CA, USA), and sequenced them on the Illlumina MiSeq platform (Genome Technology Center of NYU Medical Center, NY, USA) using a paired-end technique. Reagents for DNA extraction and for PCR amplification were sequenced as negative controls.

2.3. 16S rRNA Gene Sequence Analysis

We analyzed 16S rRNA gene sequence data using the Quantitative Insights Into Microbial Ecology (QIIME) software package (v1.8) [23]. Using qualified sequences (Phred ≥ Q20), we identified and quantified Operational Taxonomic Units (OTUs) using an open-reference method that maps sequences with 97% identity to known sequences in the Greengenes database (v13_8) [24] using UCLUST [25] and PyNAST [26] alignment algorithms. We used ChimeraSlayer to identify chimeric sequences. Negative-control derived OTUs were discarded from the OTU table using a filtration script ( in QIIME.
We rarefied to 1634 reads per sample to calculate microbial diversity. We calculated alpha diversity using the phylogenetic distance and the detected number of species metrics. Principle coordinate analysis (PCoA) with weighted Unifrac distance metric were used to evaluate beta diversity (i.e., the variation in microbial community composition) between C-section and vaginally-delivered neonatal fecal samples [27]. We performed permutational multivariate analysis of variance (PERMANOVA) to determine the significance of differences in beta diversity by delivery mode. PERMANOVA, which partitions inter-group and intra-group distances, is a permutation-based extension of multivariate analysis of variance to a matrix of pairwise distances [28]. We also used non-parametric t tests with 10,000 Monte Carlo permutations for significant test of microbial diversity.
We used linear discriminant analysis (LDA) effect size (LEfSe) [29] to identify biologically and statistically significant differences OTU relative abundance. We then used Phylogenetics Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) to predict the metabolic function of the metagenomes from the 16S rRNA gene dataset [30], with Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthologs classification [31]. An LDA score of >3 (among OTUs with at least >1% relative abundance in any group) was used to determine significant differences in abundance of OTUs and metabolic pathways.

3. Results

3.1. Neonates and Samples

Of the 78 neonates that provided meconium samples, 59 (75.6%) had bacterial DNA present in their meconium. There were no significant differences in the clinical characteristics of mothers or neonates who had meconium with vs. without detectable bacterial DNA. Of the 59 neonates with meconium bacterial DNA, 50 also provided a subsequent transitional stool sample with bacterial DNA. We analyzed the meconium and transitional stool from these neonates for the current study. Demographic, clinical, and anthropometric characteristics of the 59 neonates (13 from vaginally-delivered neonates; 46 from C-section neonates) who had meconium with detectable bacterial DNA (and their mothers) are presented in Table 1 according to delivery mode.

3.2. Microbial Community Diversity, Abundance and Predicted Function

We obtained 604,570 sequences (paired-end, Phred ≥ Q20) from the 59 meconium samples, and 472,165 sequences from the 50 transitional stools. There was an average of 9878 reads per sample, binned into 5939 Operating Taxonomic Units (OTUs; Table S1). Alpha diversity was greater for meconium than for transitional stool samples, regardless of delivery mode (Figure 1; Phylogenetic diversity whole tree, p < 0.005; Observed species, p < 0.05).
Microbial community structure (beta diversity) did not differ significantly by delivery mode in the meconium (Figure 2A; Weighted UniFrac; PERMANOVA, p = 0.1047). It did, however, vary in the transitional stools (Figure 2B; Weighted UniFrac; PERMANOVA, p < 0.0001). There were also inter-individual differences in microbiota (Figure S1), which varied by group. Transitional stool samples had higher variability then meconium, particularly transitional stools from babies born vaginally (Figure 2D and Figures S1 and S2A; Weighted UniFrac; non-parametric t-test, p < 0.001).
Both variability and the bacterial community structure in the neonatal gut changed during the transition from meconium to the transitional stool (Figure 2A,B and Figures S1 and S2A). We used linear discriminant analysis (LDA) effect size (LEfSe), retaining bacterial OTUs with >1% abundance, and found no significant delivery-mode differences in meconium microbiota. However, in the transitional-stool microbiota, LEfSe detected a significantly higher relative abundance of the genera Bacteroidetes, Parabacteroides and Clostridium in vaginally-delivered neonates as compared to C-section delivered neonates (LDA > 3.0; Figure 3).
Microbial metagenomic functioning predictions using PICRUSt provided further insight into the predicted metagenome functional profiles, again showing delivery-mode differences in the transitional stools, but not in the meconium samples (Table 2). Of note, transitional stool from the vaginally-delivered neonates had a higher proportion of bacterial genes related to amino sugar and nucleotide sugar metabolism, whereas stool microbiota from C-section neonates had higher abundance of genes related to tryptophan, valine, leucine and isoleucine degradation, fatty acid metabolism, and xenobiotics biodegradation and metabolism (LDA > 3.0; Table 2). Interestingly, microbiota differences in the transition of C-section neonatal fecal samples (Figure S2A) did not translate into differences in predicted microbial-metagenomic functional profiles, as they did in vaginally-delivered neonatal fecal samples (Table 2; Figure S2B). These results indicate relatively slower maturation of microbiome metabolic functions in the gut of C-section vs. vaginally-delivered neonates during the first days of life.

4. Discussion

In our cohort from Southern Brazil, we found that the transition from meconium to stool involves altered bacterial structure, composition and decreasing alpha diversity, and that delivery mode-associated differences in bacterial diversity, OTU abundances and predicted metagenomic functions arise not in the meconium, but in the transitional stool passed after meconium.
Our findings on the transition in microbiome composition and structure from meconium to transitional stool are consistent with previous work reporting loss of alpha diversity postnatally in mice [32] and human neonates [33]. Selective environmental pressures, such as human milk oligosaccharides found in breast milk, may drive the reduction in microbial diversity from meconium to transitional stool. Our finding (Figure S2A) that initial blooms of Streptococous and several Proteobacteria phylotypes in meconium were replaced by bacteria in the Clostridiaceae family (e.g., Lactobacillus spp.) in transitional stool of vaginally born neonates, is also consistent with findings in mice [32]. Lactobacilli are facultative anaerobes that ferment milk lactose and casein and produce lactate [34,35,36]. Lactic acid lowers the pH of the intestinal contents, inhibiting growth of obligate anaerobes [35,37] commonly found in meconium. The role of this initial reduction in diversity on education of host immune development and metabolic health remains to be elucidated.
Previous investigations on the impact of delivery mode on meconium bacterial composition have been mixed, with some studies having found differences [15,16,38], and others [39] not. Rocio et al. reported differences in bacterial counts in the meconium by mode of delivery among 108 neonates (80 vaginally-delivered and 28 C-section) [16]. They also reported differences in microbiota composition over the first 3 months, analyzing 33 different bacterial taxa by quantitative reverse transcription PCR in meconium, 2nd-day stool (transitional stool), and 7-, 30-, and 90-day stools; it is unclear from their study when compositional differences emerged [16]. Our statistical power to detect large differences may have been limited by the relatively small number of vaginally-delivered neonates in our sample. However, we were able to discern microbiota differences in transitional stools from 10 vaginally-delivered and 40 C-section neonates, and these findings are consistent with a larger sample of transitional stools [40]. Discrepancies between our study and other studies on this topic might reflect collection, storage processing or analytic platforms [41]. Differences may also be due to inter-hospital differences in delivery-mode practices, including intrapartum antibiotic administration. While we excluded 3rd-trimester antibiotics, the standard protocol for operative C-section in our hospital in Porto Alegre is intravenous intrapartum administration of cefazolin (half-life ~120 min), 30 to 60 min before surgery [42,43]. A recent study found intrapartum antibiotics were associated with an impacted infant microbiome [14]. Thus, it is possible the impact of C-section observed in our study includes the effect of intrapartum antibiotics.
Our amplicon-sequencing results compliment previous studies [10,11,12] that demonstrated mother-to-newborn transmission at the strain level. Makino et al. have shown that stains found in the mother before delivery, were also found in the meconium [10]. They have also reported the differences in transmission Bifidobacterium strains by delivery mode in 12 vaginally-delivered neonates and 5 C-section neonates, but only at 3 days after birth [11]. In the light of studies showing evidence of bacterial DNA in amniotic fluid [44,45], chorioamnion tissue [46], cord blood [47], fetal membranes [48], and the placenta [19], some investigators have taken evidence of bacterial DNA in meconium to suggest potential translocation of microbiota from mother to fetus before birth. This has been called the ‘in-utero colonization hypothesis’ [41]. However, no study, to our knowledge, has shown evidence of live bacteria in utero in healthy pregnancies. Regardless of viability, intrauterine maternal bacterial DNA might be important in intestinal transcriptional profiles programming of the offspring conferring to them protection against pathogen colonization [49].
The detection of bacterial DNA in the meconium samples in our study does not clearly support nor refute the in-utero colonization hypothesis, as meconium may reflect not only prenatal but also peri- and postnatal exposures [41]. About 75% of meconium samples in our study contained detectable microbial DNA; other studies have found similar [16] or lower prevalence of microbes in meconium [50,51,52]. Presence of microbes in meconium has been shown to increase with time [51], which one might take to support the hypothesis that intestinal colonization starts postnatally [41]. Yet, if the bacterial DNA present in the meconium of our study was acquired postnatally, one would expect the composition and structure to be altered by delivery mode, as was observed in the microbiota of the subsequent transitional stools in our study.

5. Conclusions

In summary, we found evidence of bacterial DNA in most meconium samples and we observed that bacterial diversity in the neonatal intestinal tract decreases in the first days of life, from the passing of meconium to transitional stool. Moreover, the initial transition in neonatal intestinal bacterial structure, composition and predicted metagenome function appears to be impacted by delivery mode. Our findings also add to the literature that vaginal birth-acquired microbes are important in the normal development of the early neonatal gut microbiota development and also their metabolic function, since C-section delivered neonates fail to show transitional changes in predicted bacterial metagenomic functions. Future research should determine whether the differential transition of these pioneering microbial communities and their metagenomic functions are on the pathway to the metabolic and immune-mediated diseases that have been associated with C-section delivery.

Supplementary Materials

The following are available online at: Correspondence and requests for materials should be addressed to N.T.M. and M.G.D.-B.


This study was conducted using academic funds from the Ministry of Education (Capes), and FIPE-HCPA, UFRGS. H.S. was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2017R1D1A1B03029911).

Author Contributions

N.T.M., M.G.D.-B. and H.A.S.G. designed this study. A.P., I.C.W., U.M. and M.Z.G. implemented the sample collection. N.T.M., H.S. and M.G.D.-B. performed analyses and interpreted results. N.T.M., H.S., U.M., H.A.S.G., M.Z.G. and M.G.D.-B. wrote the paper. All authors reviewed the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.


  1. Lavender, T.; Hofmeyr, G.J.; Neilson, J.P.; Kingdon, C.; Gyte, G.M. Caesarean section for non-medical reasons at term. Cochrane Database Syst. Rev. 2012, 14. [Google Scholar] [CrossRef]
  2. American College of Obstetricians and Gynecologists (College); Society for Maternal-Fetal Medicine; Caughey, A.B.; Cahill, A.G.; Guise, J.M.; Rouse, D.J. Safe prevention of the primary cesarean delivery. Am. J. Obstet. Gynecol. 2014, 210, 179–193. [Google Scholar] [CrossRef] [PubMed]
  3. Macfarlane, A.J.; Blondel, B.; Mohangoo, A.D.; Cuttini, M.; Nijhuis, J.; Novak, Z.; Olafsdottir, H.S.; Zeitlin, J.; Euro-Peristat Scientific Committee. Wide differences in mode of delivery within Europe: Risk-stratified analyses of aggregated routine data from the Euro-Peristat study. BJOG 2016, 123, 559–568. [Google Scholar] [CrossRef] [PubMed]
  4. Vieira, G.O.; Fernandes, L.G.; de Oliveira, N.F.; Silva, L.R.; Vieira Tde, O. Factors associated with cesarean delivery in public and private hospitals in a city of northeastern Brazil: A cross-sectional study. BMC Pregnancy Childbirth 2015, 15, 132. [Google Scholar] [CrossRef] [PubMed]
  5. Mueller, N.T.; Mao, G.; Bennet, W.L.; Hourigan, S.K.; Dominguez-Bello, M.G.; Appel, L.J.; Wang, X. Does vaginal delivery mitigate or strengthen the intergenerational association of overweight and obesity? Findings from the Boston Birth Cohort. Int. J Obes. 2017, 41, 497–501. [Google Scholar] [CrossRef] [PubMed]
  6. Mueller, N.T.; Whyatt, R.; Hoepner, L.; Oberfield, S.; Dominguez-Bello, M.G.; Widen, E.M.; Hassoun, A.; Perera, F.; Rundle, A. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int. J. Obes. 2015, 39, 665–670. [Google Scholar] [CrossRef] [PubMed]
  7. Mueller, N.T.; Bakacs, E.; Combellick, J.; Grigoryan, Z.; Dominguez-Bello, M.G. The infant microbiome development: Mom matters. Trends Mol. Med. 2015, 21, 109–117. [Google Scholar] [CrossRef] [PubMed]
  8. Rusconi, F.; Zugna, D.; Annesi-Maesano, I.; Baiz, N.; Barros, H.; Correia, S.; Duijts, L.; Forastiere, F.; Inskip, H.; Kelleher, C.C.; et al. Mode of Delivery and Asthma at School Age in 9 European Birth Cohorts. Am. J. Epidemiol. 2017, 185, 465–473. [Google Scholar] [CrossRef] [PubMed]
  9. Martinez, K.A.; Devlin, J.C.; Lacher, C.R.; Yin, Y.; Cai, Y.; Wang, J.; Dominguez-Bello, M.G. Increased weight gain by C-section: Functional significance of the primordial microbiome. Sci. Adv. 2017, 3. [Google Scholar] [CrossRef] [PubMed]
  10. Makino, H.; Kushiro, A.; Ishikawa, E.; Muylaert, D.; Kubota, H.; Sakai, T.; Oishi, K.; Martin, R.; Ben Amor, K.; Oozeer, R.; et al. Transmission of intestinal Bifidobacterium longum subsp. longum strains from mother to infant, determined by multilocus sequencing typing and amplified fragment length polymorphism. Appl. Environ. Microbiol. 2011, 77, 6788–6793. [Google Scholar] [CrossRef] [PubMed]
  11. Makino, H.; Kushiro, A.; Ishikawa, E.; Kubota, H.; Gawad, A.; Sakai, T.; Oishi, K.; Martin, R.; Ben-Amor, K.; Knol, J.; et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant’s microbiota. PLoS ONE 2013, 8. [Google Scholar] [CrossRef] [PubMed]
  12. Jost, T.; Lacroix, C.; Braegger, C.P.; Rochat, F.; Chassard, C. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environ. Microbiol. 2014, 16, 2891–2904. [Google Scholar] [CrossRef] [PubMed]
  13. Funkhouser, L.J.; Bordenstein, S.R. Mom knows best: The universality of maternal microbial transmission. PLoS Biol. 2013, 11. [Google Scholar] [CrossRef] [PubMed]
  14. Azad, M.B.; Konya, T.; Persaud, R.R.; Guttman, D.S.; Chari, R.S.; Field, C.J.; Sears, M.R.; Mandhane, P.J.; Turvey, S.E.; Subbarao, P.; et al. Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: A prospective cohort study. BJOG 2016, 123, 983–993. [Google Scholar] [CrossRef] [PubMed]
  15. Dominguez-Bello, M.G.; Costello, E.K.; Contreras, M.; Magris, M.; Hidalgo, G.; Fierer, N.; Knight, R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. USA 2010, 107, 11971–11975. [Google Scholar] [CrossRef] [PubMed]
  16. Martin, R.; Makino, H.; Cetinyurek Yavuz, A.; Ben-Amor, K.; Roelofs, M.; Ishikawa, E.; Kubota, H.; Swinkels, S.; Sakai, T.; Oishi, K.; et al. Early-Life Events, Including Mode of Delivery and Type of Feeding, Siblings and Gender, Shape the Developing Gut Microbiota. PLoS ONE 2016, 11. [Google Scholar] [CrossRef] [PubMed]
  17. Shin, H.; Pei, Z.; Martinez, K.A.; Rivera-Vinas, J.I.; Mendez, K.; Cavallin, H.; Dominguez-Bello, M.G. The first microbial environment of infants born by C-section: The operating room microbes. Microbiome 2015, 3, 59. [Google Scholar] [CrossRef] [PubMed]
  18. Bokulich, N.A.; Chung, J.; Battaglia, T.; Henderson, N.; Jay, M.; Li, H.; Lieber, A.D.; Wu, F.; Perez-Perez, G.I.; Chen, Y.; et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci. Transl. Med. 2016, 8. [Google Scholar] [CrossRef] [PubMed]
  19. Aagaard, K.; Ma, J.; Antony, K.M.; Ganu, R.; Petrosino, J.; Versalovic, J. The placenta harbors a unique microbiome. Sci. Transl. Med. 2014, 6. [Google Scholar] [CrossRef] [PubMed]
  20. Romano-Keeler, J.; Moore, D.J.; Wang, C.; Brucker, R.M.; Fonnesbeck, C.; Slaughter, J.C.; Li, H.; Curran, D.P.; Meng, S.; Correa, H.; et al. Early life establishment of site-specific microbial communities in the gut. Gut Microbes 2014, 5, 192–201. [Google Scholar] [CrossRef] [PubMed]
  21. Walker, R.W.; Clemente, J.C.; Peter, I.; Loos, R.J.F. The prenatal gut microbiome: Are we colonized with bacteria in utero? Pediatr. Obes. 2017, 12 (Suppl. 1), 3–17. [Google Scholar] [CrossRef] [PubMed]
  22. Caporaso, J.G.; Lauber, C.L.; Walters, W.A.; Berg-Lyons, D.; Lozupone, C.A.; Turnbaugh, P.J.; Fierer, N.; Knight, R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA. 2011, 108 (Suppl. 1), 4516–4522. [Google Scholar] [CrossRef] [PubMed]
  23. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336. [Google Scholar] [CrossRef] [PubMed]
  24. DeSantis, T.Z.; Hugenholtz, P.; Larsen, N.; Rojas, M.; Brodie, E.L.; Keller, K.; Huber, T.; Dalevi, D.; Hu, P.; Andersen, G.L. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 2006, 72, 5069–5072. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Edgar, R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26, 2460–2461. [Google Scholar] [CrossRef] [PubMed]
  26. Caporaso, J.G.; Bittinger, K.; Bushman, F.D.; DeSantis, T.Z.; Andersen, G.L.; Knight, R. PyNAST: A flexible tool for aligning sequences to a template alignment. Bioinformatics 2010, 26, 266–267. [Google Scholar] [CrossRef] [PubMed]
  27. Lozupone, C.; Hamady, M.; Knight, R. UniFrac—An online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 2006, 7, 371. [Google Scholar] [CrossRef] [PubMed]
  28. Kelly, B.J.; Gross, R.; Bittinger, K.; Sherrill-Mix, S.; Lewis, J.D.; Collman, R.G.; Bushman, F.D.; Li, H. Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA. Bioinformatics 2015, 31, 2461–2468. [Google Scholar] [CrossRef] [PubMed]
  29. Segata, N.; Izard, J.; Waldron, L.; Gevers, D.; Miropolsky, L.; Garrett, W.S.; Huttenhower, C. Metagenomic biomarker discovery and explanation. Gen. Biol. 2011, 12. [Google Scholar] [CrossRef] [PubMed]
  30. Langille, M.G.; Zaneveld, J.; Caporaso, J.G.; McDonald, D.; Knights, D.; Reyes, J.A.; Clemente, J.C.; Burkepile, D.E.; Vega Thurber, R.L.; Knight, R.; et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013, 31, 814–821. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Kanehisa, M.; Goto, S.; Sato, Y.; Kawashima, M.; Furumichi, M.; Tanabe, M. Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res. 2014, 42. [Google Scholar] [CrossRef] [PubMed]
  32. Pantoja-Feliciano, I.G.; Clemente, J.C.; Costello, E.K.; Perez, M.E.; Blaser, M.J.; Knight, R.; Dominguez-Bello, M.G. Biphasic assembly of the murine intestinal microbiota during early development. ISME J. 2013, 7, 1112–1115. [Google Scholar] [CrossRef] [PubMed]
  33. Dominguez-Bello, M.G.; De Jesus-Laboy, K.M.; Shen, N.; Cox, L.M.; Amir, A.; Gonzalez, A.; Bokulich, N.A.; Song, S.J.; Hoashi, M.; Rivera-Vinas, J.I.; et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat. Med. 2016, 22, 250–253. [Google Scholar] [CrossRef] [PubMed]
  34. Kunji, E.R.; Mierau, I.; Hagting, A.; Poolman, B.; Konings, W.N. The proteolytic systems of lactic acid bacteria. Antonie Van Leeuwenhoek 1996, 70, 187–221. [Google Scholar] [CrossRef] [PubMed]
  35. Jiang, T.; Savaiano, D.A. In vitro lactose fermentation by human colonic bacteria is modified by Lactobacillus acidophilus supplementation. J. Nutr. 1997, 127, 1489–1495. [Google Scholar] [PubMed]
  36. Angelakis, E.; Armougom, F.; Million, M.; Raoult, D. The relationship between gut microbiota and weight gain in humans. Future Microbiol. 2012, 7, 91–109. [Google Scholar] [CrossRef] [PubMed]
  37. Soergel, K.H. Colonic fermentation: Metabolic and clinical implications. Clin. Investig. 1994, 72, 742–748. [Google Scholar] [CrossRef] [PubMed]
  38. Nagpal, R.; Tsuji, H.; Takahashi, T.; Kawashima, K.; Nagata, S.; Nomoto, K.; Yamashiro, Y. Sensitive Quantitative Analysis of the Meconium Bacterial Microbiota in Healthy Term Infants Born Vaginally or by Cesarean Section. Front. Microbiol. 2016, 7, 1997. [Google Scholar] [CrossRef] [PubMed]
  39. Chu, D.M.; Ma, J.; Prince, A.L.; Antony, K.M.; Seferovic, M.D.; Aagaard, K.M. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat. Med. 2017, 23, 314–326. [Google Scholar] [CrossRef] [PubMed]
  40. Mueller, N.T.; Shin, H.; Pizoni, A.; Werlang, I.C.; Matte, U.; Goldani, M.Z.; Goldani, H.A.; Dominguez-Bello, M.G. Birth mode-dependent association between pre-pregnancy maternal weight status and the neonatal intestinal microbiome. Sci. Rep. 2016, 6, 23133. [Google Scholar] [CrossRef] [PubMed]
  41. Perez-Munoz, M.E.; Arrieta, M.C.; Ramer-Tait, A.E.; Walter, J. A critical assessment of the “sterile womb” and “in utero colonization” hypotheses: Implications for research on the pioneer infant microbiome. Microbiome 2017, 5, 48. [Google Scholar] [CrossRef] [PubMed]
  42. Heineck, I.; Ferreira, M.B.; Schenkel, E.P. Prescribing practice for antibiotic prophylaxis for cesarean section in a teaching hospital in Brazil. Am. J. Infect. Control. 2002, 30, 341–345. [Google Scholar] [CrossRef] [PubMed]
  43. Farret, T.C.; Dalle, J.; Monteiro Vda, S.; Riche, C.V.; Antonello, V.S. Risk factors for surgical site infection following cesarean section in a Brazilian Women’s Hospital: A case-control study. Braz. J. Infect. Dis. 2015, 19, 113–117. [Google Scholar] [CrossRef] [PubMed]
  44. Nguyen, D.P.; Gerber, S.; Hohlfeld, P.; Sandrine, G.; Witkin, S.S. Mycoplasma hominis in mid-trimester amniotic fluid: Relation to pregnancy outcome. J. Perinat. Med. 2004, 32, 323–326. [Google Scholar] [CrossRef] [PubMed]
  45. Cassell, G.H.; Davis, R.O.; Waites, K.B.; Brown, M.B.; Marriott, P.A.; Stagno, S.; Davis, J.K. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16–20 weeks of gestation: Potential effect on outcome of pregnancy. Sex. Transm. Dis. 1983, 10, 294–302. [Google Scholar] [PubMed]
  46. Bearfield, C.; Davenport, E.S.; Sivapathasundaram, V.; Allaker, R.P. Possible association between amniotic fluid micro-organism infection and microflora in the mouth. BJOG 2002, 109, 527–533. [Google Scholar] [CrossRef] [PubMed]
  47. Jimenez, E.; Fernandez, L.; Marin, M.L.; Martin, R.; Odriozola, J.M.; Nueno-Palop, C.; Narbad, A.; Olivares, M.; Xaus, J.; Rodriguez, J.M. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr. Microbiol. 2005, 51, 270–274. [Google Scholar] [CrossRef] [PubMed]
  48. Steel, J.H.; Malatos, S.; Kennea, N.; Edwards, A.D.; Miles, L.; Duggan, P.; Reynolds, P.R.; Feldman, R.G.; Sullivan, M.H. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr. Res. 2005, 57, 404–411. [Google Scholar] [CrossRef] [PubMed]
  49. Gomez de Aguero, M.; Ganal-Vonarburg, S.C.; Fuhrer, T.; Rupp, S.; Uchimura, Y.; Li, H.; Steinert, A.; Heikenwalder, M.; Hapfelmeier, S.; Sauer, U.; et al. The maternal microbiota drives early postnatal innate immune development. Science 2016, 351, 1296–1302. [Google Scholar] [CrossRef] [PubMed]
  50. Koleva, P.T.; Kim, J.S.; Scott, J.A.; Kozyrskyj, A.L. Microbial programming of health and disease starts during fetal life. Birth Defects Res. C Embryo Today 2015, 105, 265–277. [Google Scholar] [CrossRef] [PubMed]
  51. Hansen, R.; Scott, K.P.; Khan, S.; Martin, J.C.; Berry, S.H.; Stevenson, M.; Okpapi, A.; Munro, M.J.; Hold, G.L. First-Pass Meconium Samples from Healthy Term Vaginally-Delivered Neonates: An Analysis of the Microbiota. PLoS ONE 2015, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Sunderarajan, K.; Kelkar, S.S. Bacterial flora of meconium and faeces during the first year of life. Indian J. Pediatr. 1979, 46, 92–95. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Bacterial alpha diversity in the meconium and transitional stool by delivery mode. Samples were rarefied to 1634 reads per sample. The nonparametric p values were calculated using 100,000 Monte Carlo permutation. Different letters indicate significant differences (e.g., ‘a’ is significantly different from ‘b’, but not significantly different from ‘a’); Statistical significance for phylogenetic diversity (PD) whole tree, p < 0.005; Observed species, p < 0.05. +, outlier samples.
Figure 1. Bacterial alpha diversity in the meconium and transitional stool by delivery mode. Samples were rarefied to 1634 reads per sample. The nonparametric p values were calculated using 100,000 Monte Carlo permutation. Different letters indicate significant differences (e.g., ‘a’ is significantly different from ‘b’, but not significantly different from ‘a’); Statistical significance for phylogenetic diversity (PD) whole tree, p < 0.005; Observed species, p < 0.05. +, outlier samples.
Genes 08 00364 g001
Figure 2. Bacterial diversity in the meconium and transitional stool by delivery mode. (AC) Principal Coordinate Analysis (PCoA) plot of bacterial communities in meconium (A) and transitional stool (B) by delivery mode. Weighted UniFrac distances were used to evaluate diversity between samples. PERMANOVA was used to test dissimilarity. (C) Box plot of intra-group distances. The non-parametric p values were calculated using 100,000 Monte Carlo permutation. Different letters (a, b and c) indicate significant differences; p < 0.001.
Figure 2. Bacterial diversity in the meconium and transitional stool by delivery mode. (AC) Principal Coordinate Analysis (PCoA) plot of bacterial communities in meconium (A) and transitional stool (B) by delivery mode. Weighted UniFrac distances were used to evaluate diversity between samples. PERMANOVA was used to test dissimilarity. (C) Box plot of intra-group distances. The non-parametric p values were calculated using 100,000 Monte Carlo permutation. Different letters (a, b and c) indicate significant differences; p < 0.001.
Genes 08 00364 g002
Figure 3. Bacterial taxa comparisons in meconium and transitional stool by delivery mode. (A) Each taxonomy (>1% of average relative abundance in any groups) is indicated by a different color at the genus level. ** Indicates overrepresented taxa (using LDA > 3.0) in comparisons of delivery mode within sample type. (B) Histogram of overrepresented taxa (using LDA > 3.0) in each group.
Figure 3. Bacterial taxa comparisons in meconium and transitional stool by delivery mode. (A) Each taxonomy (>1% of average relative abundance in any groups) is indicated by a different color at the genus level. ** Indicates overrepresented taxa (using LDA > 3.0) in comparisons of delivery mode within sample type. (B) Histogram of overrepresented taxa (using LDA > 3.0) in each group.
Genes 08 00364 g003
Table 1. Characteristics * of Brazilian mothers and their newborns who had meconium microbiota.
Table 1. Characteristics * of Brazilian mothers and their newborns who had meconium microbiota.
Vaginal Delivery
(n = 13)
C-Section Delivery
(n = 46)
Maternal characteristics
Mothers age, y28.5 (5.9)30.5 (4.7)
Mothers race
White, n (%)12 (92)42 (91)
Non-white, n (%)1 (8)4 (9)
Urinary tract infection
Yes, n (%)4 (31)6 (13)
No, n (%)9 (69)40 (87)
Medications in pregnancy
Yes, n (%)4 (31)19 (41)
No, n (%)9 (69)27 (59)
Antibiotics in pregnancy
None, n (%)9 (69)36 (78)
1st Trimester, n (%)1 (8)5 (11)
2nd Trimester, n (%)3 (23)5 (11)
Ever smoke tobacco
Yes (%)0 (0)12 (26)
No (%)13 (100)34 (74)
Pre-pregnancy BMI, kg/m222.4 (3.2)25.3 (5.0)
Pregnancy weight gain, kg13.0 (3.0)13.7 (5.4)
Newborn characteristics
Boy, n (%)3 (23)30 (65)
Girl, n (%)10 (77)16 (35)
Birth weight, g 3127.6 (334.5)3234.3 (427.4)
Birth length, cm48.7 (2.2)48.9 (1.6)
Head circumference, cm 35.9 (4.4)35.7 (2.8)
Placenta weight, g §674.8 (91.3)624.2 (131.7)
Breastfed 1st 24 h
Yes, n (%)13 (100)40 (87)
No, n (%)0 (0)6 (13)
* values expressed as mean (standard deviation) if not otherwise indicated as n (%); based on 10 vaginally-delivered and 43 C-section delivered neonates with data; § based on 10 vaginally-delivered and 39 C-section delivered neonates with data.
Table 2. Predictive KEGG functional profiling of microbiota from transitional stools—but not from meconium—differ by delivery mode. *
Table 2. Predictive KEGG functional profiling of microbiota from transitional stools—but not from meconium—differ by delivery mode. *
Transitional StoolMeconium
KEGG Functional CategoriesVaginal Delivery (n = 10)Vs.
Delivery (n = 40)
Vaginal Delivery (n = 13)Vs.
Delivery (n = 46)
Level 2Level 3LDAP ValueLDA
Amino Acid MetabolismTryptophan metabolism-0.01635→ 3.06No
Amino Acid MetabolismValine/leucine/isoleucine degradation-0.0066→ 3.12
Carbohydrate MetabolismAmino sugar/nucleotide sugar metabolism3.16 ←0.03282-
Enzyme FamiliesPeptidases3.20 ←0.0049-
Lipid MetabolismFatty acid metabolism-0.00946→ 3.04
Metabolism of Cofactors/Vitamins-3.22 ←0.03282-
Metabolism of Cofactors/VitaminsPorphyrin/chlorophyll metabolism3.03 ←0.02905-
Metabolism of Terpenoids/Polyketides--0.01864→ 3.01
Xenobiotics Biodegradation and Metabolism--0.00881→ 3.67
* Significantly overrepresented KEGG functional categories in predicted metagenomes by delivery mode were detected using Linear Discriminant Analysis (LDA) Effect Size >3.0-fold with direction indicated by arrow (← or →).

Share and Cite

MDPI and ACS Style

Mueller, N.T.; Shin, H.; Pizoni, A.; Werlang, I.C.; Matte, U.; Goldani, M.Z.; Goldani, H.A.S.; Dominguez-Bello, M.G. Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function. Genes 2017, 8, 364.

AMA Style

Mueller NT, Shin H, Pizoni A, Werlang IC, Matte U, Goldani MZ, Goldani HAS, Dominguez-Bello MG. Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function. Genes. 2017; 8(12):364.

Chicago/Turabian Style

Mueller, Noel T., Hakdong Shin, Aline Pizoni, Isabel C. Werlang, Ursula Matte, Marcelo Z. Goldani, Helena A. S. Goldani, and Maria G. Dominguez-Bello. 2017. "Delivery Mode and the Transition of Pioneering Gut-Microbiota Structure, Composition and Predicted Metabolic Function" Genes 8, no. 12: 364.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop